Skip to main content
. 2020 Aug 13;7(9):ofaa350. doi: 10.1093/ofid/ofaa350

Table 1.

Systematic Review of COVID-19 in Pregnancy and the Peripartum Period

Total No. of Cases (n = 11 308) No. (%)
Estimated gestational age (n = 2824)a
1st trimester (1–12 wk) 66 (2)
2nd trimester (13–27 wk) 574 (20)
3rd trimester (>28 wk) 2184 (77)
Symptoms (n = 11 308)
Cough 2704 (24)
Fever 2051 (18)
Fatigue, malaise, myalgias 1525 (13)
Headache 1448 (13)
Shortness of breath, dyspnea 1391 (12)
Otherb 4120 (36)
Asymptomatic 366 (3)
Severity (as defined by authors; n = 1999)
Mild–moderatec 1583 (79)
Severe/ICU 416 (21)
Investigational treatment reported (n = 184)d
Hydroxychloroquine 106 (58)
Lopinavir/ritonavir 39 (21)
Remdesivir 13 (7)
IL-1, IL-6 inhibitors 13 (7)
IVIG or gamma globulin 9 (5)
Convalescent plasma 4 (2)
Maternal outcomes (n = 10 597)
Alive to delivery 10 437 (98)
Died 33 (0.3)
Still hospitalized 127 (1.0)
Pregnancy outcomes (n = 2297)
Live births 1375 (60)
In utero, pregnancy ongoing 869 (38)
Spontaneous miscarriage (<20 wk) 20 (0.9)
Elective abortion 17 (0.7)
Stillbirth (>20 wk) 14 (0.6)
Ectopic pregnancy 2 (0.08)
Gestational age at birth (n = 868)
Term 695 (80)
Preterm (<37 wk) 173 (20)
Delivery type (n = 871)
Vaginal delivery 259 (30)
Cesarean section 612 (70)
Neonatal outcomes (n = 1163)
Alive 1155 (99)
Neonatal death 8 (0.7)

Abbreviations: ICU, intensive care unit; IL, interleukin; IVIG, intravenous immunoglobulin.

aOne large cohort study (n = 8207) did not have estimated gestational ages available.

bOther symptoms included diarrhea (n = 596), nausea/vomiting (n = 700), sore throat (n = 1005), loss of taste or smell (n = 803), and chills (n = 1016).

cIncluded asymptomatic cases.

dTreatment received at any time during pregnancy or postpartum after the time of COVID-19 diagnosis. Some women may have received multiple treatments.